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Table 1
metoprolol nebivalol carvedilol p
Male 38 (59.4%)a 21 (35%)b 32 (53.3%)a.b 0,02
Female 26 (40.6%)a 39 (65%)b 28 (46.7%)a.b 0.02
Diabetes
Mellitus
17 (26.6%) 20 (33.3%) 14 (23.3%) 0.494
Hypertension 51 (79.7%)a 33 (55%)b 36 (60%)b 0.008
Hyperlipidemia 29 (45.3%)a 9 (15%)b 14 (23.3%)b 0.001
Family History
of coronary
heart disease
9 (14.1%) 3 (5%) 5 (8.3%) 0.228
Smoking 29 (45.3%)a 14 (23.3%)b 25 (41.7%)a.b 0.023
Statin 33 (51.6%) 25 (41.7%) 28 (46.7%) 0.532
ACE 27 (42.2%) 16 (26.7%) 16 (26.7%) 0.114
ARB 18 (28.1%) 14 (23.3%) 16 (26.7%) 0.871
Tiazide 5 (7.8%) 6 (10%) 6 (10%) 0.902
Trimetazidin 3 (4.7%) 4 (6.7%) 3 (5%) 0.925
Metformine 10 (15.6%) 12 (20%) 7 (11.7%) 0.466
CIN 7 (10.9%) 5 (8.3%) 2 (3.3%) 0.283
Categorical distributions of various characteristics of the participants
Table 2
Metoprolol Nebivolol Carvedilol p
Age y 59.89.74a 58.2310.6a.b 54.5510.23b 0.014
BMI kg/m2 30.514.68 31.2814.18 29.934.77 0.711
EF % 58.149.88 60.459.96 57.7510.1 0.107
Mehran score 3.532.86 3.852.93 3.373.02 0.515
Total contrast
dose ml
127.9773.66a 99.6739.44a 104.6779.86b 0.009
Creatinine
clearance
89.1220.46 94.6425.98 96.6926.20 0.2
Basal
creatinine
0.890.21a 0.80.2b 0.80.16b 0.023
Second day
creatinine
0.920.26a 0.840.22a 0.820.17b 0.029
Fiﬁth day
creatinine
0.900.19a 0.810.20b 0.810.14b 0.008
HB 13.291.48 12.861.34 12.92.17 0.290
LDL 116.5434.5 115.5234.3 119.2141.1 0.855
TG 161.2389.2 168.27151.5 180.38122.3 0.753
Glukose 114.7237.3 118.9757.8 116.8753.9 0.652
Numerical data of the distribution of various characteritics of participants
Demographic charecteristics
Average age (years) 61,6 (36-85)
Diyabetes Mellitus (%) 56,0
Hyperlipidemia (%) 56,0
Cigarette (%) 37,8
Coronary Artery Disease (%) 87,8
Hypertension (%) 70,7
Gender (male %) 87,1
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Early and Midterm Outcomes of Percutaneous Treatment of Symtomatic
Stenosis of Lower Extremity and Chronic Limb Ischemia
Sakir Arslan, Isa Oner Yuksel, Erkan Koklu, Goksel Cagırcı, Selcuk Kucukseymen,
Nermin Bayar, Akar Yilmaz, Zehra Erkal, Cem Yunus Bas, Gorkem Kus, Murat Esin
Antalya Education and Research Hospital, Antalya
Objectıves: Our goal is to evaluate the effectiveness, reliability, advantages and the
results of early-to-mid-term of percutaneous treatment of lower extremity strictures.
Background: Technological advances in the past decade have shifted revasculari-
zation strategies from traditional open surgical approaches toward lower-morbidity
percutaneous endovascular treatments for patients with lower extremity peripheral
arterial disease (PAD). The role of endovascular interventions is also expanding in the
treatment of limb-threatening ischemia. Especially in chronic limb ischemia and foot
ulcers, diabetic patients with inoperable, there is growing interest below the knee
interventions.
Methods: Between May 2011 and May 2013, 85 patients with stenosis of the lower
limb arteries (iliac-femoral-popliteal-below the knee) and treated percutaneously,
enrolled in the study. Although medical therapy, patients with intermittent claudica-
tion and have >70% stenosis in iliac or femoral artery, stenting procedure was per-
formed after primary stenting or balloon angioplasty. Symptomatic patients withC224 JACC Vo>70% stenosis of popliteal or below-knee artery, balloon angioplasty was performed.
After the patients were followed up clinically.
Results: Tecnical success was achieved in 84 patients (98,8%). Predilatation before
stent placement, 33,3% of cases performed. Post dilation procedure was performed in
66,6% of patients with used the self-expanding stent. 84 patients with iliac-femoral
artery stenosis, stenting procedure is applied and concomitantly 6 patients with
popliteal artery and distal to the stenosis, the balloon angioplasty was performed.
Average follow-up time was 10,06,3 months. (1 – 25 Months). Including death,
myocardial infarction, major bleeding complications were not observed depending on
percutaneous procedures. Iliac stent in a patient as a complication inferior vena cava
ﬁstula formation, this complication was treated using a stent-graft. 7 patients with
diabetes and foot wounds that never heal, healed wounds were observed during
follow-up after the procedure. In the clinical follow-up, claudication complaints
decreased and increased walking distances observed.
Conclusıon: Technical success rate and early-midterm outcomes of percutaneous
treatment for PAD are magniﬁcent. We believe that percutaneous treatment methods
in lower extremity arterial stenosis, will be more widespread with percutaneous
treatment techniques and operator experience increases.PP-361
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Mehmet Serdar Soydinç, Sait Alan, Mehmet Sıddık Ülgen
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Objectıve: We sought to evaluate our clinical experience and short-term results of
percutaneous closure of patent ductus arteriosus (PDA).
Materıals-Methods: We studied 20 patients (17 female, mean age 248 years)
undergoing percutaneous closure of PDA between March 2010-March 2013 in our
clinic. Amplatzer duct occluder (ADO) I was used in 13 patients and ADO II was used
in 7 patients for PDA closure. Clinical charecteristics of patients, properties of
percutaneous closure intervention, complications and short-term results are evaluated.
Results: The mean ductus waist diameter measured by angiographic examination was
52 mm (2-9 mm). Procedure was successfully performed in all patients. Occluder
device embolization was occurred in one patient in whom device was retrieved by
snare catheter and PDA was successfully closed with same device. The early total
occlusion rate was 85%. Occlusion rate as determined by echocardiographic control
performed the day after was 95% whereas 100% at ﬁrst month. In the follow-up of
199 months, no complications were observed.
Conclusıon: Percutaneous closure of PDA using ADO I and II devices are safe and
effective.
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Comparison of Clinical and Angiographic Parameters Right Coronary Artery
Shapes in Patients With Acute Myocardial Infarction from Right Coronary
Artery
Mehmet Sait Altıntas¸1, Necip Ermis¸1, Bilal Çuglan2, Erdal Altürk3,
Ramazan Özdemir1
1Inonu University, School of Medicine, Department of Cardiology, Malatya, 2Malatya
State Hospital, Malatya, 3Adiyaman 82. Yil State Hospital, Adiyaman
Purpose: Atherosclerosis is associated with the hemodynamic factors emerged from
the geometry of vessels outside of the traditional risk factors. When compared C and S
(sigma) shape of right coronary artery (RCA), C shape was found to be more asso-
ciated with coronary artery disease in previous studies. However, in patients admitted
with acute myocardial infarction(AMI) from the RCA, the effect of these two
geometric shape of RCA did not evaluated on TIMI frame count (TFC), distribution
and length of the lesion. The aim this study was to compare intracoronary ﬂow rates,
localization and severity of lesion between C and S shapes of RCA on coronary
angiography images by evaluation of angiographic images of primary percutaneous
interventions in AMI which is caused by RCA in our center.
Methods: The angiographic images of 163 of patients were evaluated who performed
primary percutaneous intervention due to AMI from RCA. Patients were divided into
two groups according to the geometric shape of RCA. Clinical and angiographic
parameters were compared in terms of C and S shapes of RCA.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
